Introduction
The oral microbiota is the second most complex microbial ecosystem after the gut flora, consisting of a dynamic spectrum of microorganisms residing in the oral cavity and its interaction with host genetics, diet, immune system, and many other factors [
1]. The bacterial microbiome is the predominant component, with species consisting mainly of obligate aerobes such as
Neisseria and
Rothia, facultative aerobes such as
Streptococcus and
Actinomyces, and obligate anaerobes including
Firmicutes,
Bacteroidetes, and
Spirochaetes [
2]. The community composition, although similar amongst the buccal mucosa, gingiva, and hard palate; yet is different from the soft surfaces, saliva, and gingival plaques [
3]. Saprophytic protozoa such as
Entamoeba gingivalis and
Trichomonas tenax and fungi such as
Candida albicans and
Saccharomyces cerevisiae are also native residents of oral microbiota [
1].
Despite the similarities in the core microbial composition existing within oral cavities, the species may vary depending on the host's diet and nutrition, genetic predisposition, hormonal factors, antibiotic exposure, alcohol consumption, and repeated infections by pathogenic bacteria. This variation, if pathogenic, is termed dysbiosis, which can cause several alterations to the host's oral and systemic health through multiple pathophysiological processes [
4,
5]. Dysbiosis has been reported to be involved in the etiology of oral diseases such as dental caries, gingivitis, and periodontitis; and systemic diseases spanning from infections to cancers, such as respiratory tract infections, gastric ulcers, irritable bowel disease, rheumatoid arthritis, infective endocarditis, and cancers [
1,
4,
6].
Tobacco smoking is a well-known preventable cause of death and affects nearly every organ system of the body [
7]. The oral cavity is one of the first regions exposed to cigarette smoke and is at a prime disadvantage for increased carcinogenesis, impaired mucosal immunity, and alteration of the oral microbiome [
8‐
10]. In turn, smoking increases colonization of the oral cavity by pathogenic bacteria and reduces colonization by commensal bacteria [
11,
12]. Smoking enhances biofilm formation and results in greater epithelial adherence by certain pathogens, including
Streptococcus pneumonia,
Staphylococcus aureus,
Streptococcus mutans; thereby, increasing susceptibility to respiratory infections and dental caries respectively in those smokers [
8,
10,
12]. Furthermore, smoking contributes to the alteration in the oxygen tension of the oral and upper gastrointestinal microenvironment that encourages persistence of microaerophilic bacteria replacing the commensal beneficial species [
12,
13]. Previous studies have shown an increased prevalence of the genera
Atopobium,
Campylobacter, and
Prevotella among smokers and selective depletion of certain phyla, including
Proteobacteria [
12,
14‐
16]. Thus, tobacco smoking creates a unique dysbiotic environment in the oral cavity, influencing the microbiota composition with far-reaching consequences in the local and systemic health of the host [
8]. In this study, we intend to decipher our understanding of the oral microbiota's composition and its alteration due to tobacco smoking and smoking severity (nicotine dependence level). Further, we evaluated the metabolic capabilities of the oral microbiota using shotgun metagenomic sequencing to determine microbial biodiversity and functional capabilities that associate with tobacco smoking in the oral cavity.
Discussion
The mouth is a highly heterogeneous ecological system with dynamic interplay between the host and oral microbiome [
27]. The collective function of microbial communities is a major determinant of homeostasis or dysbiosis, and host factors such as inflammation and dietary sugars may ultimately favor health or disease such as dental caries and periodontitis [
28]. In this report, we attempted to explore oral microbial profiles and functions that influence host homeostasis in the background of cigarette smoking. We explored the oral microbiota of chronic tobacco smokers in the Middle-Eastern population and described, for the first time, the functional contribution of the oral bacterial community based on nicotine dependence assessed by the Fagerström scale [
17]. A final study population of 105 subjects, with an average age of 30 years, recruited in northern emirates of UAE was used for shotgun metagenomics analysis. We used buccal swabs, a more specific sampling method for the bio-adherent bacteria as compared to mouth wash sampling previously conducted in a UAE based-study [
29]. Consistent with several previous reports, we detected a significant taxonomic difference between smoker and non-smoker groups, but no significant differences in terms of microbial diversity and richness, as shown in Additional file
1: Figure S3 [
30‐
32]. Interestingly, a previous study conducted in the UAE determined only a marginal significance of the overall oral microbial differences in smokers compared with non-smokers, underscoring the geographic and ethnic contribution [
29]. However, our findings were not consistent with other groups reporting a significant change in richness and diversity [
33,
34]. The observed fluctuations in oral microbiota richness and diversity reporting by several groups are not unusual and further assert the high complexity and significant effects of several factors such as diet, geography, ethnicity, and host factors. That said, the oral microbiota in our study exhibit comparable dominance of phyla
Firmicutes,
Proteobacteria,
Actinobacteria,
Bacteroidetes, and genera
Prevotella and
Veillonella to that of oral microbiota in other populations across the globe [
16,
34,
35].
Differential abundance testing of bacterial communities based on nicotine dependence scores revealed a relative abundance of
Streptobacillus hongkongensis among more nicotine dependent smokers (high Fagerström score). Previous studies reported the isolation of
S. hongkongensis from patients with quinsy, pneumonia, and septic arthritis [
36,
37], which was later reported as part of the human oropharynx natural reservoir [
38]. Increased risk of developing serious respiratory illnesses might be partly attributed to more nicotine dependent smokers. That said, we acknowledge that the overall number of reads attributed to this species is generally very low and requires further validation. Furthermore, complications of streptobacilliary infections may include endocarditis, brain abscesses, amnionitis, as well as persistent severe arthritis [
39].
Smoking tobacco is the single largest risk factor for the development of lung cancers. Several studies established that
Fusobacterium nucleatum plays a major role in colorectal carcinogenesis via Fap2 mediated binding to tumor-overexpressed Gal-GalNAc-binding lectin [
40‐
42]. Therefore,
F. nucleatum was deemed useful as a microbial biomarker for colorectal cancer detection [
43]. Interestingly, we discovered that the phylogenetically similar
Fusobacterium massiliense, which exhibited substantial sequence similarity with
F. nucleatum, has a significant relative abundance among more nicotine dependent smokers. Furthermore, protein–protein BLAST analysis of the Fap2 surface protein of
F. nucleatum ATCC 23,726 produced a significant sequence alignment with pyridoxal phosphate-dependent aminotransferase of
F. massiliense [
41,
44], the active form of vitamin B6. A previous study examined over 44,000 individuals and evaluated their smoking history and B6 vitamin supplement use over 10 years, this study found that high dosages of vitamin B6 supplements were associated with 3–4 folds increase in lung cancer risk among smokers at baseline, although the exact mechanism of this association is not yet known [
45].
Fusobacterium, similar to
Bacteroides,
Bifidobacterium,
Actinobacteria, and
Proteobacteria, possess a vitamin B6 biosynthesis pathway.
Bacteroidetes and
Proteobacteria likely produce vitamin B6, starting from deoxyxylulose 5-phosphate and 4-phosphohydroxy-l-threonine [
29]. Several prevailing hypotheses may explain the link. First, several B vitamins, including B6, B9 (folate), and B12 interact with homocysteine and methionine in this complex one-carbon metabolism pathway, and disruption of this process may promote carcinogenesis [
46]. Second, a study reported that among B6 metabolism markers, it was the inflammation-related changes in a vitamin B6 catabolism marker, the 4-pyridoxic acid/pyridoxal plus pyridoxal 5′-phosphate ratio, which was linked to increased lung cancer risk [
47]. Third, excessive supplementation of folic acid and vitamin B12 was found to be associated with changes in DNA methylation of several genes that could be reactivated or deregulated during carcinogenesis [
48]. Altogether, perhaps enrichment of
F. massiliense among more nicotine dependent smokers suggest a possible linkage to lung cancer in a pyridoxal phosphate-dependent manner. Tobacco smoking, colorectal cancer, and a high relative abundance of gut
Prevotella were linked to each other in an intriguing association [
49]. Here, we also noted an increase in the relative abundance of
Prevotella sp000163055 and
Prevotella bivia in oral microbiota of heavy smokers, thereby suggesting a possible downstream effect on the development of colorectal cancers.
The metabolic capabilities of oral microbiota were evaluated using a shotgun metagenomic sequencing approach to determine microbial biodiversity and functional capabilities associated with tobacco smoking in the oral cavity. Functional profiling showed significant enrichment of Tricarballylate utilization among smokers
vs. non-smokers group, a good chelator of magnesium that could lead to magnesium deficiency [
50]. Magnesium plays a vital role in tobacco addiction by inhibiting several essential steps of nicotine addiction, such as dopamine secretion, NMDA receptor stimulation by glutamate, and the synthesis of substance P and nitric oxide [
51,
52]. A previous study showed a significant decrease in the number of cigarettes smoked and Fagerström scores after 28 days of magnesium therapy [
53]. This observation of enriched bacterial genes involved in Tricarballylate utilization among smokers suggests an intriguing role of oral dysbiosis in maintaining nicotine addiction. Moreover, a significant increase in the nickel-dependent lactate racemase enzymes was observed in smokers, consistent with the toxic nickel exposure from tobacco smoking [
54,
55].
Finally, we examined the differentially abundant gene functions in correlation with the Fagerström score for nicotine dependence among smokers. Significant enrichment of xanthosine utilization was observed among more nicotine dependent smokers, which is a catabolite of purine nucleotides that leads to caffeine synthesis [
56]. This enrichment could be linked to the positive association between smoking and coffee consumption, in which heavy smokers require greater coffee consumption than others to obtain an equivalent satisfactory effect of caffeine, as reported in a study of two European cohorts [
57]. Lastly, we noted an enrichment of the Multidrug efflux pump in
Campylobacter jejuni (CmeABC operon) biosynthesis module in the heavy smokers' group, an important component of bacterial virulence that can predispose heavy smokers to additional risk of tobacco-related morbidity and mortality [
58]. It is important to mention that our findings need further validation on a larger cohort. The data obtained from self-administered questionnaires was subject to self-reporting bias; however, a study staff was available during the questionnaire to answer any questions.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.